- Home
- KNDI vs PYXS Comparison
KNDI vs PYXS Comparison
Compare KNDI & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- PYXS
- Stock Information
- Founded
- KNDI 2002
- PYXS 2018
- Country
- KNDI China
- PYXS United States
- Employees
- KNDI N/A
- PYXS N/A
- Industry
- KNDI Auto Manufacturing
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- KNDI Consumer Discretionary
- PYXS Health Care
- Exchange
- KNDI Nasdaq
- PYXS Nasdaq
- Market Cap
- KNDI 96.3M
- PYXS 75.0M
- IPO Year
- KNDI N/A
- PYXS 2021
- Fundamental
- Price
- KNDI $1.20
- PYXS $1.14
- Analyst Decision
- KNDI
- PYXS Strong Buy
- Analyst Count
- KNDI 0
- PYXS 5
- Target Price
- KNDI N/A
- PYXS $9.00
- AVG Volume (30 Days)
- KNDI 109.2K
- PYXS 706.6K
- Earning Date
- KNDI 08-15-2025
- PYXS 08-13-2025
- Dividend Yield
- KNDI N/A
- PYXS N/A
- EPS Growth
- KNDI N/A
- PYXS N/A
- EPS
- KNDI N/A
- PYXS N/A
- Revenue
- KNDI $127,569,613.00
- PYXS N/A
- Revenue This Year
- KNDI N/A
- PYXS N/A
- Revenue Next Year
- KNDI N/A
- PYXS N/A
- P/E Ratio
- KNDI N/A
- PYXS N/A
- Revenue Growth
- KNDI 3.21
- PYXS N/A
- 52 Week Low
- KNDI $0.89
- PYXS $0.83
- 52 Week High
- KNDI $2.07
- PYXS $5.39
- Technical
- Relative Strength Index (RSI)
- KNDI 52.54
- PYXS 51.02
- Support Level
- KNDI $1.09
- PYXS $1.04
- Resistance Level
- KNDI $1.17
- PYXS $1.24
- Average True Range (ATR)
- KNDI 0.07
- PYXS 0.08
- MACD
- KNDI 0.01
- PYXS -0.00
- Stochastic Oscillator
- KNDI 61.23
- PYXS 53.57
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.